Entera Bio Statistics
Total Valuation
Entera Bio has a market cap or net worth of $61.03 million. The enterprise value is $50.48 million.
Important Dates
The last earnings date was Friday, November 8, 2024, after market close.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Entera Bio has 36.83 million shares outstanding. The number of shares has increased by 22.42% in one year.
Current Share Class | 36.83M |
Shares Outstanding | 36.83M |
Shares Change (YoY) | +22.42% |
Shares Change (QoQ) | +1.49% |
Owned by Insiders (%) | 2.22% |
Owned by Institutions (%) | 3.91% |
Float | 26.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 8.77 |
P/TBV Ratio | 8.85 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 509.94 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.05.
Current Ratio | 6.61 |
Quick Ratio | 6.26 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -144.67% and return on invested capital (ROIC) is -85.93%.
Return on Equity (ROE) | -144.67% |
Return on Assets (ROA) | -70.61% |
Return on Capital (ROIC) | -85.93% |
Revenue Per Employee | $5,500 |
Profits Per Employee | -$509,889 |
Employee Count | 18 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +112.33% in the last 52 weeks. The beta is 1.59, so Entera Bio's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | +112.33% |
50-Day Moving Average | 1.84 |
200-Day Moving Average | 1.82 |
Relative Strength Index (RSI) | 31.37 |
Average Volume (20 Days) | 130,999 |
Short Selling Information
Short Interest | 44,153 |
Short Previous Month | 40,395 |
Short % of Shares Out | 0.12% |
Short % of Float | 0.17% |
Short Ratio (days to cover) | 1.98 |
Income Statement
In the last 12 months, Entera Bio had revenue of $99,000 and -$9.18 million in losses. Loss per share was -$0.26.
Revenue | 99,000 |
Gross Profit | 9,000 |
Operating Income | -9.21M |
Pretax Income | -8.51M |
Net Income | -9.18M |
EBITDA | -9.16M |
EBIT | -9.21M |
Loss Per Share | -$0.26 |
Full Income Statement Balance Sheet
The company has $6.92 million in cash and $309,000 in debt, giving a net cash position of $6.61 million or $0.18 per share.
Cash & Cash Equivalents | 6.92M |
Total Debt | 309,000 |
Net Cash | 6.61M |
Net Cash Per Share | $0.18 |
Equity (Book Value) | 6.45M |
Book Value Per Share | 0.18 |
Working Capital | 6.23M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$7.97 million and capital expenditures -$5,000, giving a free cash flow of -$7.97 million.
Operating Cash Flow | -7.97M |
Capital Expenditures | -5,000 |
Free Cash Flow | -7.97M |
FCF Per Share | -$0.22 |
Full Cash Flow Statement Margins
Gross Margin | 9.09% |
Operating Margin | -9,304.04% |
Pretax Margin | -9,270.71% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -12,884.21% |
Dividends & Yields
Entera Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.42% |
Shareholder Yield | -22.42% |
Earnings Yield | -16.08% |
FCF Yield | -13.97% |
Analyst Forecast
The average price target for Entera Bio is $10.00, which is 503.50% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.00 |
Price Target Difference | 503.50% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Entera Bio has an Altman Z-Score of 0.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.12 |
Piotroski F-Score | 3 |